Number of Risk Factors in Down Syndrome Pregnancies

Abstract

Objective The objective of this study was to evaluate risk factor prevalence in pregnancies with fetal Down syndrome, in an effort to characterize efficacy of population-based screening.

Study Design Retrospective review of singleton pregnancies with delivery of live born or stillborn infant with Down syndrome from 2009 through 2015. Risk factor categories included maternal age ≥35 years, abnormal serum screening, identification of ≥1 ultrasound marker at 16 to 22 weeks (nuchal thickness ≥6 mm, echogenic intracardiac focus, echogenic bowel, renal pelvis dilatation, femur length <third percentile), and detection of a major fetal anomaly. Statistical analyses included χ² test and Mantel–Haenszel χ² test.

Results Down syndrome infants represented 1:428 singleton births. All risk categories were assessed in 125 pregnancies and included abnormal serum screen in 110 (88%), ≥1 ultrasound marker in 66 (53%), and ≥1 anomaly in 41 (34%). The calculated risk was at least 1:270 in 93% of Down syndrome pregnancies. More pregnancies had multiple risk factors than had a single risk factor, 90 (72%) versus 30 (24%), p < 0.001. An abnormal ultrasound marker or anomaly was identified in >50% of fetuses in women <35 years and in >75% of those 35 years and older.

Conclusion In a population-based cohort, sensitivity of second-trimester Down syndrome screening was 93%, with multiple risk factors present in nearly three-fourths of cases.

Keywords

Down syndrome - ultrasound markers - serum aneuploidy screening

Note

This study was presented at the Society for Maternal-Fetal Medicine 37th Annual Meeting, Las Vegas, NV.

• References

• 1 Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998; 12 (01) 8-14
• 2 Bromley B, Lieberman E, Shipp TD, Benacerraf BR. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002; 21 (10) 1087-1096
• 3 Committee on Practice Bulletins—Obstetrics and the American Institute of Ultrasound in Medicine. Practice Bulletin No. 175: ultrasound in pregnancy. Obstet Gynecol 2016; 128 (06) e241-e256
• 4 Practice Bulletin No. 163 Summary: screening for fetal aneuploidy. Obstet Gynecol 2016; 127 (05) 979-981
• 5 Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995; 172 (03) 837-844
• 6 Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181 (01) 129-133
• 7 Cunningham FG, Leveno KJ, Bloom SL. , et al , eds. Williams Obstetrics, 25th ed. New York: McGraw-Hill; 2018: 286-287
• 8 Bahado-Singh RO, Oz UA, Mendilcioglu I, Mahoney MJ. The mid-trimester genetic sonogram. Semin Perinatol 2005; 29 (04) 209-214
• 9 Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013; 41 (03) 247-261
• 10 Morris JK, Garne E, Wellesley D. , et al. Major congenital anomalies in babies born with Down syndrome: a EUROCAT population-based registry study. Am J Med Genet A 2014; 164A (12) 2979-2986
• 11 Rankin J, Tennant PW, Bythell M, Pearce MS. Predictors of survival in children born with Down syndrome: a registry-based study. Pediatrics 2012; 129 (06) e1373-e1381
• 12 Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet 2015; 58 (12) 674-680
• 13 Hamilton BE, Martin JA, Osterman MJK, Curtin SC. Births: Preliminary Data for 2014. National Vital Statistics Reports; Vol 64 no 6. Hyattsville, MD: National Center for Health Statistics; 2015
• 14 Loane M, Morris JK, Addor M-C. , et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 2013; 21 (01) 27-33
• 15 Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2015. NCHS Data Brief, No 258. Hyattsville, MD: National Center for Health Statistics; 2016
• 16 Mai CT, Kucik JE, Isenburg J. , et al; National Birth Defects Prevention Network. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol 2013; 97 (11) 709-725
• 17 Malone FD, Canick JA, Ball RH. , et al; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353 (19) 2001-2011
• 18 Baer RJ, Flessel MC, Jelliffe-Pawlowski LL. , et al. Detection rates for aneuploidy by first-trimester and sequential screening. Obstet Gynecol 2015; 126 (04) 753-759
• 19 Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45 (03) 249-266
• 20 de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A 2015; 167A [phone]
• 21 Kuppermann M, Pena S, Bishop JT. , et al. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA 2014; 312 (12) 1210-1217
• 22 Aagaard-Tillery KM, Malone FD, Nyberg DA. , et al; First and Second Trimester Evaluation of Risk Research Consortium. Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009; 114 (06) 1189-1196